Evidence map›Paper›PMID 26066624›Full record

ArticlePloS one2015

HIV-1 Myristoylated Nef Treatment of Murine Microglial Cells Activates Inducible Nitric Oxide Synthase, NO2 Production and Neurotoxic Activity.

Giorgio Mangino, Marylinda Famiglietti, Caterina Capone, Caterina Veroni, Zulema Antonia Percario, Stefano Leone, Gianna Fiorucci, Sebastian Lülf, Giovanna Romeo, Cristina Agresti and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Oxidative Stress during HIV Infection: Mechanisms and Consequences.Oxidative medicine and cellular longevity · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Giorgio ManginoDepartment of Science, University Roma Tre, Rome, Italy; Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
Marylinda FamigliettiDepartment of Science, University Roma Tre, Rome, Italy.
Caterina CaponeDepartment of Science, University Roma Tre, Rome, Italy.
Caterina VeroniDepartment of Cell Biology and Neuroscience, Istituto Superiore di Sanità, Rome, Italy.
Zulema Antonia PercarioDepartment of Science, University Roma Tre, Rome, Italy.
Stefano LeoneDepartment of Science, University Roma Tre, Rome, Italy.
Gianna FiorucciInstitute of Molecular Biology and Pathology, CNR, Rome, Italy.
Sebastian LülfCenter of Advanced European Studies and Research, Group of Physical Biochemistry, Bonn, Germany.
Giovanna RomeoDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Institute of Molecular Biology and Pathology, CNR, Rome, Italy.
Cristina AgrestiDepartment of Cell Biology and Neuroscience, Istituto Superiore di Sanità, Rome, Italy.
Tiziana PersichiniDepartment of Science, University Roma Tre, Rome, Italy.
Matthias GeyerCenter of Advanced European Studies and Research, Group of Physical Biochemistry, Bonn, Germany.
Elisabetta AffabrisDepartment of Science, University Roma Tre, Rome, Italy.
Roma Tre University · ITCenter of Advanced European Studies and Research · DEIstituto Superiore di Sanità · ITInstitute of Molecular Biology and Pathology · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe potential role of the human immunodeficiency virus-1 (HIV-1) accessory protein Nef in the pathogenesis of neuroAIDS is still poorly understood. Nef is a molecular adapter that influences several cellular signal transduction events and membrane trafficking. In human macrophages, Nef expression induces the production of extracellular factors (e.g. pro-inflammatory chemokines and cytokines) and the recruitment of T cells, thus favoring their infection and its own transfer to uninfected cells via exosomes, cellular protrusions or cell-to-cell contacts. Murine cells are normally not permissive for HIV-1 but, in transgenic mice, Nef is a major disease determinant. Both in human and murine macrophages, myristoylated Nef (myr+Nef) treatment has been shown to activate NF-κB, MAP kinases and interferon responsive factor 3 (IRF-3), thereby inducing tyrosine phosphorylation of signal transducers and activator of transcription (STAT)-1, STAT-2 and STAT-3 through the production of proinflammatory factors. METHODOLOGY/PRINCIPAL

findingsWe report that treatment of BV-2 murine microglial cells with myr+Nef leads to STAT-1, -2 and -3 tyrosine phosphorylation and upregulates the expression of inducible nitric oxide synthase (iNOS) with production of nitric oxide. We provide evidence that extracellular Nef regulates iNOS expression through NF-κB activation and, at least in part, interferon-β (IFNβ) release that acts in concert with Nef. All of these effects require both myristoylation and a highly conserved acidic cluster in the viral protein. Finally, we report that Nef induces the release of neurotoxic factors in the supernatants of microglial cells.

conclusionsThese results suggest a potential role of extracellular Nef in promoting neuronal injury in the murine model. They also indicate a possible interplay between Nef and host factors in the pathogenesis of neuroAIDS through the production of reactive nitrogen species in microglial cells.

Indexed as

AnimalsBlotting, WesternCells, CulturedCytokinesHumansImmunoenzyme TechniquesInterferon-gammaMacrophagesMiceMicrogliaMitogen-Activated Protein KinasesMyristic Acidnef Gene Products, Human Immunodeficiency VirusNF-kappa BNitric OxideNitric Oxide Synthase Type IICytokinesInterferon-gammaMitogen-Activated Protein KinasesMyristic Acidnef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1NF-kappa BNitric OxideNitric Oxide Synthase Type IINOS2 protein, humanRNA, Messenger

Identifiers

PMID26066624
PMCPMC4465743
OpenAlexW811863687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.